Cytomx Thera (CTMX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2014 | 09-2014 | 12-2013 | |
| Cash Flows From Operating Activities | |||
| Net Income | -30,310 | -25,523 | -15,140 |
| Depreciation Amortization | 820 | 592 | 660 |
| Accounts receivable | N/A | -317 | N/A |
| Accounts payable and accrued liabilities | N/A | 444 | N/A |
| Other Working Capital | 60,670 | 60,678 | 5,950 |
| Other Operating Activity | 620 | 326 | 530 |
| Operating Cash Flow | $31,800 | $36,200 | $-8,000 |
| Cash Flows From Investing Activities | |||
| PPE Investments | -1,660 | -999 | -730 |
| Investing Cash Flow | $-1,660 | $-999 | $-730 |
| Cash Flows From Financing Activities | |||
| Debt Repayment | N/A | -917 | N/A |
| Common Stock Issued | N/A | 8 | N/A |
| Other Financing Activity | 25,550 | 10,316 | 2,690 |
| Financing Cash Flow | $25,550 | $9,407 | $2,690 |
| Beginning Cash Position | 8,700 | 8,703 | 14,740 |
| End Cash Position | 64,390 | 53,311 | 8,700 |
| Net Cash Flow | $55,690 | $44,608 | $-6,040 |
| Free Cash Flow | |||
| Operating Cash Flow | 31,800 | 36,200 | -8,000 |
| Capital Expenditure | N/A | -999 | N/A |
| Free Cash Flow | 31,800 | 35,201 | -8,000 |